The 20 Best Basal Cell Skin Cancer Doctors Near Me in Ypsilanti, MI

Dr. Christopher Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School.Dr. Bichakjian is a foremost expert in the field of cutaneous surgery and oncology. He has a special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006. He has presented over 100 national and international invited lectures and visiting professorships, and authored or co-authored nearly 90 peer-reviewed publications with a primary focus on cutaneous oncology.Dr. Bichakjian received his medical degree from Radboud University in The Netherlands. After relocating to the US, he completed residency in dermatology and fellowship in micrographic surgery and cutaneous oncology at Michigan Medicine. He subsequently practiced Mohs surgery in private practice and served as adjunct faculty at Weill Medical College at Cornell University in New York City.In 2004, Dr. Bichakjian was recruited back to Ann Arbor to join the faculty in the Department of Dermatology at Michigan Medicine. He served as director of the UM Multidisciplinary Merkel Cell Carcinoma Program for more than a decade (2006-2017), In addition, he served as chief of the Division of Cutaneous Surgery and Oncology and as director of the Multidisciplinary Melanoma Program in the Rogel Cancer Center from 2017-2020. Dr. Bichakjian is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Basal Cell Skin Cancer, Melanoma, and Eccrine Porocarcinoma. Dr. Bichakjian is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

In 2008, Dr. Dlugosz was named Poth Professor of Cutaneous Oncology in the Dermatology Department at the University of Michigan in Ann Arbor. He is Scientific Director of the Cutaneous Oncology Program of the University of Michigan Comprehensive Cancer Center. He received his M.D. at the Pennsylvania State University College of Medicine in 1984, did an internship at the Roger Williams General Hospital in Providence, RI, and completed his dermatology residency, including a year as Chief Resident, at the University of Pennsylvania in Philadelphia, in 1988. He received his post-doctoral training with Dr. Stuart Yuspa at the National Cancer Institute, where he subsequently established an independent research program prior to his recruitment to the University of Michigan in 1997.Dr. Dlugosz has received multiple awards, grants, and fellowships from the National Institutes of Health, American Cancer Society, American Association for Cancer Research, Society for Investigative Dermatology, and Dermatology Foundation. He was elected to the American Society for Clinical Investigation in 2002, has been included in the Best Doctors in America listing since 2003, and was elected to the American Dermatological Association in 2005.The National Institutes of Health and other scientific agencies frequently enlist Dr. Dlugosz as a grant reviewer. He is also an ad hoc reviewer for multiple scholarly journals, and is frequently invited to speak, or chair sessions, at major scientific meetings both in the United States and abroad. Dr. Dlugosz is an author on over 60 published papers.Dr. Dlugosz's basic research program is centered on two interrelated areas. He is investigating how the abnormal regulation of an embryonic signaling pathway, called the Hedgehog pathway, causes tumor development in skin and several other organs. In other studies, he is investigating the role of the Hedgehog pathway in development, growth, and regeneration of hair follicles and related structures. Dr. Dlugosz is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 88 other conditions, according to our data. His clinical expertise encompasses Cicatricial Pemphigoid, Pemphigus, Bullous Pemphigoid, and Pemphigus Vulgaris. Dr. Dlugosz is board certified in Dermatology.

Montgomery Gillard is a Dermatologist practicing medicine in Ypsilanti, Michigan. Dr. Gillard is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Timothy Johnson is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Melanoma, Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, and Merkel Cell Carcinoma.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringoma, and Syringocystadenoma Papilliferum. Dr. Lowe is board certified in Dermatology and Dermatopathology.

Hyuk Cha is a Dermatologist practicing medicine in Ypsilanti, Michigan. Dr. Cha is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Actinic Keratosis, Intertrigo, Warts, and Erythroderma.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

"Dr. Michael J. Davis is a Clinical Assistant Professor and board-certified Mohs surgeon and dermatologist in the Michigan Medicine Department of Dermatology. He provides expert care for patients with high-risk and advanced skin cancer in the Cutaneous Surgery and Oncology outpatient clinic at the UM Rogel Cancer Center and is a member of the multidisciplinary cutaneous oncology program.Dr. Davis graduated from the School of Medicine at Emory University, completed a dermatology residency at Dartmouth University, and pursued a Micrographic Surgery and Dermatologic Oncology clinical fellowship at Scripps Health in La Jolla, California. He completed a one-year Cutaneous Oncology Research Fellowship at Memorial Sloan Kettering Cancer Center, where he also served as an instructor of dermatology and interim assistant director of the Mohs lab for the Dermatology Service.Dr. Davis’s clinical and scholarly interests center on cutaneous surgery and oncology, with an emphasis on Mohs histopathology. He has co-authored seven chapters for the ""Laboratory Manual for Mohs Micrographic Surgery Frozen Tissue Processing,"" a comprehensive reference on the Mohs tissue processing technique (Springer, April 2024). He is an active member of the American Academy of Dermatology, the American Society for Dermatologic Surgery, the American College of Mohs Surgery, and the International Immunosuppression and Transplant Skin Cancer Collaborative.". Dr. Davis is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Davis is board certified in Micrographic Dermatologic Surgery and Dermatology.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Dr. Maya Aravind is a board-certified dermatologist and Assistant Professor of Dermatology at the University of Michigan. She provides medical dermatology diagnosis and treatment to patients of all ages within in our medical dermatology outpatient clinics.Dr. Aravind received her medical degree from the University of Michigan Medical School, and her master of science degree in clinical research from the University of Michigan School of Public Health Rackham School of Graduate Studies. Following graduation, she completed her transitional year internship at Oakwood Hospital in Dearborn, MI, and her dermatology residency at the U-M Department of Dermatology. Dr. Aravind practiced dermatology in Tennessee and Texas before joining the clinical faculty of the University of Michigan Department of Dermatology in 2022. Dr. Aravind is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Warts, and Seborrheic Keratosis.

Jenny Cotton is a Dermatologist practicing medicine in Ypsilanti, Michigan. Dr. Cotton is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Proliferating Trichilemmal Cyst, Basal Cell Skin Cancer, Actinic Keratosis, and Epidermoid Cyst.

Timothy Vandenboom is a Dermatologist practicing medicine in Ypsilanti, Michigan. Dr. Vandenboom is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Actinic Keratosis, Syringocystadenoma Papilliferum, and Syringoma.

Stephen Olsen is a Dermatologist practicing medicine in Ypsilanti, Michigan. Dr. Olsen is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Actinic Keratosis, Extramammary Paget Disease, and Warts.

Dr. Sara Fossum is Clinical Assistant Professor of Dermatology and a board-certified dermatologist in the Michigan Medicine Department of Dermatology. She provides medical dermatology diagnosis and treatment to patients of all ages in our medical dermatology outpatient clinics. She has special interests in complex medical dermatology including the care of patients with bullous skin disease and hidradenitis suppurativa. Dr. Fossum is a graduate of the Medical Scientist Training Program at Northwestern University Feinberg School of Medicine where she received her medical degree and PhD degree in life sciences. Following graduation, she completed her preliminary year internship in internal medicine at Northshore University Health System in Evanston, Illinois, and her dermatology residency at the University of Michigan Department of Dermatology, where she served as co-chief resident in her final year. Dr. Fossum joined the U-M Dermatology faculty in January 2023. Dr. Fossum is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Hidradenitis Suppurativa, Melanoma, Bullous Pemphigoid, and Pyoderma Gangrenosum.

Aleodor Andea is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Andea is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Tieche-Jadassohn Nevus, Melanoma, Syringoma, and Basal Cell Skin Cancer.

Scott Bresler is a Pathologist and a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Bresler is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Syringoma, Syringocystadenoma Papilliferum, Sebaceous Adenoma, and Basal Cell Skin Cancer. Dr. Bresler is board certified in Dermatopathology and Pathology-Anatomic/Pathology-Clinical.

Mallory Smith is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, and Sunburn.

Dr. Jennifer Schwartz received her medical degree from Northwestern University Medical School and completed her internship in internal medicine at Northwestern Medical Center in Chicago. She completed her dermatology residency at the University of Michigan Department of Dermatology and two years of specialty training in melanoma at the U-M Rogel Cancer Center.Additionally, she completed advanced specialty training in cutaneous surgery treatment of benign and malignant lesions at the University of Michigan. In 1999, Dr. Schwartz became a faculty member of the Melanoma and Cutaneous Oncology and Surgery Program. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Melanoma, Eccrine Porocarcinoma, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schwartz is board certified in Dermatology.